Praxis Precision Medicines | 10-Q:2024财年三季报
Praxis Precision Medicines | 8-K:Praxis Precision Medicines提供公司最新情况并报告2024年第三季度财务业绩
Praxis Precision Medicines | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(5.85%)
Praxis Precision Medicines | SC 13G:超过5%持股股东披露文件-BlackRock, Inc.(7.3%)
Praxis Precision Medicines | 8-K:重大事件
Praxis Precision Medicines | SC 13G:超过5%持股股东披露文件-Perceptive Advisors LLC(6.3%),Joseph Edelman(6.3%)等
Praxis Precision Medicines | 8-K:重大事件
Praxis Precision Medicines | 10-Q:2024财年二季报
Praxis Precision Medicines | 8-K:Praxis Precision Medicines提供公司最新情况并报告2024年第二季度财务业绩
Praxis Precision Medicines | 4:持股变动声明-高管 Souza Marcio
Praxis Precision Medicines | 4:持股变动声明-高管 Nemiroff Alex
Praxis Precision Medicines | 4:持股变动声明-高管 Mastrocola Lauren
Praxis Precision Medicines | 4:持股变动声明-高管 Kelly Timothy Edwin
Praxis Precision Medicines | SC 13G:超过5%持股股东披露文件-RA Capital Management, L.P.(7.2%),Peter Kolchinsky(7.2%)等
Praxis Precision Medicines | S-8 POS:员工福利计划证券登记(修正)
Praxis Precision Medicines | 4:持股变动声明-董事 DeSimone Jill
Praxis Precision Medicines | 4:持股变动声明-董事 MITCHELL DEAN J
Praxis Precision Medicines | 4:持股变动声明-董事 Chodakewitz Jeffrey
Praxis Precision Medicines | 4:持股变动声明-董事 Cudkowicz Merit Ester
Praxis Precision Medicines | 4:持股变动声明-董事 YOUNG WILLIAM D
暂无数据
暂无数据